Immatics (IMTX) Cash & Equivalents (2019 - 2026)

Immatics has reported Cash & Equivalents for 7 years, with the latest figure at $402.7 million in Q4 2025.

• Quarterly Cash & Equivalents rose 59.16% year-over-year to $402.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $402.7 million (up 59.16% YoY) and the FY2025 annual result came in at $390.8 million, up 52.52% from the prior year.
• Cash & Equivalents advanced to $402.7 million in Q4 2025 per IMTX's latest filing, from $391.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $402.7 million in Q4 2025 and troughed at $90.8 million in Q3 2023.
• A 5-year average of $219.0 million and a median of $200.3 million in 2021 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents tumbled 54.4% in 2023, then jumped 128.74% in 2024.
• Over 5 years, Cash & Equivalents stood at $152.1 million in 2021, then decreased by 0.4% to $151.5 million in 2022, then surged by 55.13% to $235.1 million in 2023, then rose by 7.63% to $253.0 million in 2024, then surged by 59.16% to $402.7 million in 2025.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $402.7 million, $391.5 million, and $290.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.